P. Lardenois

Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's disease.

M. Castel, P. Barnéoud, T. Rooney, 2019, Bioorganic & medicinal chemistry letters.

A Convenient Synthesis 7,8-Dihydroisoquinolin-5(6H)-One

J. Frost, P. George, P. Lardenois, 1996 .